Terns Pharmaceuticals Inc (TERN)

SG&A Expenses

$8.70M

Quarterly · Period ending: · USD

TERN logo

TERN SG&A Expenses

Latest reported$8.70M
TERN Quarterly SG&A Expenses ($2.39M → $8.70M)
High-resolution chart · PNG

TERN sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Terns Pharmaceuticals Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
8,699,000
7,799,000
7,030,000
8,707,000
7,945,000
9,770,000
7,185,000
6,859,000
6,599,000
18,353,000
7,008,000
7,101,000
6,170,000
5,131,000
5,422,000
5,689,000
5,416,000
4,715,000
4,857,000
4,561,000
998,000
3,333,000
2,486,000
2,179,000
2,388,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.